Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results

Provided By PR Newswire

Last update: Jan 13, 2025

Cash, Cash Equivalents and Short-Term Investments Increased Approximately $15.5 million in the Fourth Quarter of 2024

REDWOOD CITY, Calif., Jan. 13, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced its preliminary, unaudited fourth-quarter and full-year 2024 revenue and other financial results.